Aqdot has revolutionised the encapsulation market.

Astex' fragment-based approach to the discovery of small molecule drugs is used by many major pharma companies.

Cambridge Epigenetix has used research into the role of the epigenome in disease to develop a non-invasive diagnostic kit for widespread cancer screening.

Fluidic Analytics is changing the way that protein analysis is conducted in industrial, academic and clinical settings.

A low-cost, sustainable way to create bright white pigment without using damaging chemicals such as titanium dioxide.

Nyobolt is supercharging the electric revolution with its ultra-fast charging batteries.

PharmEnable uses advanced medicinal chemistry and artificial intelligence to design potential drug therapies.

An after-work beer at the Panton Arms was the start of a DNA revolution.

Sphere Fluidics' microdroplet technology is set to automate the discovery of therapeutic monoclonal antibodies, and transform how the biopharmaceutical industry works in this area.

Xampla's goal is to eradicate the need for single-use plastics.

ZOMP's new cytometer will enable highly accurate quantitative imaging of millions of cells in a single experiment.

University programmes like Cambridge Enterprise and Accelerate are helping us to spin-out and nurture the ideas of our researchers and students into beneficial and practicable applications.